Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0000921895-17-000099

Director bought 2,130 shares at $6.51 ($13,866)

  • Director acquired 124 shares (code L)
  • Director acquired 20,227 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Eberwein Jeffrey E. Director 2017-01-20 Other acquisition +124 $6.51 $807 80,057 I
Eberwein Jeffrey E. Director 2017-01-23 Purchase +2,130 $6.51 $13,866 82,187 I
Eberwein Jeffrey E. Director 2017-01-24 Option exercise +20,227 20,227 D
Derivatives
Eberwein Jeffrey E. Director 2017-01-24 Option exercise · Restricted Stock Unit +20,227 0 D
Open-market purchases · 2,130 sh · avg $6.51 · $13,866
Loading xslF345X03/form410211002_01252017.xml…